info@efcni.org

Other content tagged: preterm

Preterm children’s long-term academic performance after adaptive computerised training

Altered brain development and academic underachievement are potential consequences of preterm birth. A recent study from Germany now showed that adaptive computerised training can increase short-term academic growth in preterm children. Low attention, working memory and mathematic scores can be the result of preterm birth, making preterm children more vulnerable to reduced academic performance. While research has shown that an adaptive working memory training (Cogmed) has no long-term benefits on school performance for preterm school-aged children, this study tested the…
Read more

RECAP preterm: the ACTION cohort

The main idea behind the Italian ACTION (ACcess To Intensive Obstetrical and Neonatal care) follow-up project was to assess the outcomes of every very preterm birth occurring in a given geographical area, as opposed to those cared for in maternities and NICUs of tertiary hospitals only, and to identify factors that could explain such outcomes and suggest possible strategies for improvement. Thus, the initial cohort recruitment in 2003-05 and collection of perinatal data up…
Read more

PARCA-R: Screening of cognitive and language delay in preterm born infants

The standardisation on over 6000 infants of the PARCA-R for the screening of cognitive and language delay has just been published in the Lancet Child & Adolescence Health. 6000 infants at the age of 2 were tested in cognitive and language development. PARCA-R stands for Parent Report of Children’s Abilities-Revised. It is a parent completed questionnaire that can be used to assess children's cognitive and language development at 24 months of age. The PARCA-R is used as an outcome measure…
Read more

EFCNI supports study by c4c research collaboration on paracetamol in preterm babies

Since last year, EFCNI has been involved as a third party representing the voice of patients and parents in the new conect4children (c4c) consortium, a research collaboration to build a European paediatric clinical trial network that aims to facilitate the development of new drugs and other therapies for the entire paediatric population. c4c now announced that it selected its first portfolio of pan-European paediatric studies aimed at advancing the understanding of high priority medicines commonly used in babies, children, and young people in Europe.…
Read more